Sort
17,828 grants matching “crispr”
Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in Cancer
$1,046,441A Thomas Look · Dana-Farber Cancer Inst · R35 · FY2017 · CA
Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in Cancer
$1,046,441A Thomas Look · Dana-Farber Cancer Inst · R35 · FY2018 · CA
Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in Cancer
$1,046,441A Thomas Look · Dana-Farber Cancer Inst · R35 · FY2021 · CA
Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in Cancer
$1,046,441A Thomas Look · Dana-Farber Cancer Inst · R35 · FY2020 · CA
Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in Cancer
$1,046,441A Thomas Look · Dana-Farber Cancer Inst · R35 · FY2016 · CA
Trans-NIH RNAi Facility (TNRF)
$1,046,097Anton Simeonov · National Center For Advancing Translational Sciences · ZIC · FY2019 · TR
Translating genomic discoveries to improved outcomes for high risk acute leukemia
$1,044,690Charles G. Mullighan · St. Jude Children'S Research Hospital · R35 · FY2019 · CA
In vivo delivery of Ab-directed CRISPR ribonucleoproteins for anal cancer immunotherapy
$1,043,843Mary Haak-Frendscho · Spotlight Therapeutics · R44 · FY2023 · CA
Discovery, Biology and Risk of Inherited Variants in Glioma
$1,043,807Melissa L Bondy · Baylor College Of Medicine · R01 · FY2018 · CA
ER Network Shaping Mechanisms in the Hereditary Spastic Paraplegias
$1,043,107Craig Blackstone · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
$1,041,188Kevin Michael Haigis · Beth Israel Deaconess Medical Center · U01 · FY2018 · CA
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
$1,041,188Kevin Michael Haigis · Beth Israel Deaconess Medical Center · U01 · FY2017 · CA
RNAi Screening in Hematopoietic Cells
$1,039,848Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Functional Genomics Laboratory (FGL)
$1,037,104Ken Cheng · National Center For Advancing Translational Sciences · ZIC · FY2025 · TR
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,036,834Aaron D. Gitler · Stanford University · R35 · FY2021 · NS
10k: A platform for immersive science education
$1,036,415Laura Lynn Gonzalez · Dynamoid, Inc. · R44 · FY2024 · GM
Validation of the Genetically Malleable Oncopig Hepatocellular carcinoma (HCC) Model for Targeted Therapeutic Development
$1,035,724Kyle Schachtschneider · Sus Clinicals, Inc. · R44 · FY2024 · CA
Pre-clinical and clinical studies of NTBC and other compounds as potential treatments for albinism
$1,035,426Brian Brooks · National Eye Institute · ZIA · FY2023 · EY
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
$1,035,000Alex Toker · Beth Israel Deaconess Medical Center · R35 · FY2021 · CA
CCR, LGI, Flow Cytometry Core
$1,034,245Ferenc Livak · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
The Cancer Target Discovery and Development Network at UCSF
$1,034,211Michael T McManus · University Of California, San Francisco · U01 · FY2017 · CA
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing
$1,033,149Luca Pinello · Massachusetts General Hospital · UM1 · FY2021 · HG
High-throughput systematic characterization of regulatory element function
$1,032,594William James Greenleaf · Stanford University · UM1 · FY2019 · HG
High-throughput systematic characterization of regulatory element function
$1,032,594William James Greenleaf · Stanford University · UM1 · FY2018 · HG
High-throughput systematic characterization of regulatory element function
$1,032,594William James Greenleaf · Stanford University · UM1 · FY2021 · HG